Project Team Bios
Project Lead: James Smith
CASMI Translational Stem Cell Consortium Program Coordinator
University of Oxford
James’ expertise spans various aspects of healthcare translation, including biomanufacturing, regulation, and intellectual property. James is a Research Associate of the CASMI Translational Stem Cell Consortium, where he is responsible for leading and conducting research into and review of various aspects of regenerative medicine commercialization. Prior to his current role, he was an SRF Summer Scholar at the Harvard Stem Cell Institute, where he investigated scale-up costs of exosomes under the supervision of Professor Jeff Karp and Executive Director Brock Reeve. Before moving to the field of healthcare translation, he worked in the R&D department of an integrated supplier of micro-ingredients for animal feeds, AB Vista, where he gained extensive experience applying advanced statistical methods in a commercial setting.
James holds an EU Regulatory Affairs Certification (RAC, EU), the only globally recognized certification for the regulatory profession. He sits on the Publications Advisory Committee and is the lead author of several chapters published by the Regulatory Affairs Professionals Society, which is the largest global organization of and for those involved with the regulation of healthcare and related products. He has also contributed to publications in several academic journals, management journals, and bioprocessing trade magazines on a range of topics. He has authored or co-authored several poster presentations and regularly speaks at a variety of international conferences.
James holds a First Class Degree in Biological Sciences from the University of Oxford, where he was an academic scholar at Worcester College. He is currently pursuing a Doctor of Philosophy Degree in which he is trying to identify methods for prediction of drug candidate success.
Project Associate: Zeeshaan Arshad
University of Cambridge
Zeeshaan Arshad comes from Scotland and reads medicine at the University of St. Andrews. He began his research career as a 2016 SRF Summer Scholar at the University of Oxford in the Bountra lab, investigating the effects of open access on drug translation. Since the end of the internship, he has continued to work with Oxford researchers on projects as diverse as looking into the effects of soft tissue augmentation, developing reporting guidelines for patent landscaping studies, and ascertaining the safety and efficacy of T-cell immunotherapy. His work has been published in leading journals and been presented at national and international conferences.
During an internship at the Memorial Sloan Kettering Cancer Centre in New York City, he studied the development of lymphedema in a murine model. He was recently awarded the prestigious Wolfson Intercalated Research Fellowship by the Royal College of Physicians to develop a machine-learning algorithm to predict outcomes in total hip replacement as part of his medical degree. In addition to winning the medal for the top performance in his first and second years at medical school, he is president and founder of the University of St Andrews Society of Oncology.